Tech Company Financing Transactions
Combinent BioMedical Systems Funding Round
On 5/7/2007, Combinent BioMedical Systems raised Series A investment from Commons Capital, Hologic and VIMAC Ventures.
Transaction Overview
Company Name
Announced On
5/7/2007
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Proceeds Purpose
This financing will be used primarily to fund clinical trials.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
420 Bedford Street 240
Lexington, MA 02420
USA
Lexington, MA 02420
USA
Phone
Website
Email Address
Not Recorded
Overview
Combinent BioMedical Systems, Inc. is an emerging specialty pharmaceutical company that is developing novel drug combinations and formulations of existing pharmaceutical products using its proprietary transvaginal drug delivery system (TVDS).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Sena Biswas
Chief Executive Officer
Peter Lanciano
Chief Financial Officer
John Ledoux
Chief Technical Officer
Eyal Ron
Browse more venture capital transactions:
Prev: 5/7/2007: Mig33 venture capital transaction
Next: 5/7/2007: LeadPoint venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs